Executive Summary / Key Takeaways
- BBU's operational transformation engine is delivering 10% same-store EBITDA growth despite headline declines from capital recycling, proving the core value creation strategy remains intact and generating substantial free cash flow of $724 million on a TTM basis.
- The partnership trades at a material discount to net asset value—management estimates roughly 50% below intrinsic value—enabling highly accretive capital allocation including $235 million in unit repurchases at an average $26 price and a secondary sale at an 8.6% discount to NAV that immediately crystallized value.
- A pending corporate reorganization into a single listed corporation represents a catalyst to unlock institutional demand, improve trading liquidity, and potentially double index-driven ownership, directly addressing the valuation gap that has persisted since its 2016 inception.
- Near-term risks center on European cyclical exposure affecting DexKo and Modulaire, technology modernization costs pressuring CDK and Scientific Games margins, and execution timing on asset monetizations like Clarios, BRK, and Latrobe.
- The investment thesis hinges on two variables: successful monetization of mature assets to recycle capital into new opportunities, and the reorganization's effectiveness in narrowing the NAV discount—if both execute, the current $30.84 price offers asymmetric upside to a business compounding value at 15-20% targets.
Setting the Scene: The Operational Transformation Flywheel
Brookfield Business Partners, founded in 2016 and headquartered in Bermuda, occupies a unique position in the alternative asset management landscape. Unlike traditional private equity firms that primarily engineer returns through financial leverage and multiple expansion, BBU operates as a permanent capital vehicle focused on operational transformation. The strategy is straightforward but difficult to replicate: acquire controlling stakes in market-leading businesses across industrials, business services, and infrastructure, then deploy Brookfield's global operating expertise to enhance performance and cash flows. This approach targets 15-20% returns on invested capital, with management consistently emphasizing that more than half of historical value realization stems from improving owned businesses rather than external market factors.
The partnership's structure as a publicly traded subsidiary of Brookfield Corporation (BN) provides distinct advantages and constraints. On one hand, BBU gains access to a $1 trillion ecosystem for co-investment capital, proprietary deal flow, and decades of operational playbooks. On the other, it suffers from persistent valuation skepticism, trading at a substantial discount to the sum of its parts. This discount has become central to the investment narrative, creating opportunities for accretive capital recycling that pure-play private equity competitors like Blackstone (BX), KKR (KKR), Apollo (APO), and Carlyle (CG) cannot replicate in the same form. While those giants compete on scale—Blackstone commands $1.3 trillion in AUM, Apollo manages $938 billion—BBU competes on depth of operational control, typically taking majority positions where it can dictate strategic direction.
The current market environment plays directly into BBU's hands. Deglobalization is forcing companies to reshore manufacturing and rethink supply chains, with U.S. manufacturing CapEx growing from $50 billion in 2020 to nearly $250 billion in 2025. Simultaneously, AI is reshaping industrial and essential services, but the constraint isn't technology—it's experienced operators who can implement real change. BBU's integrated model, combining investment capabilities with operating expertise, positions it to capture value from these structural shifts while larger competitors focus on deploying capital at scale.
History with Purpose: From Inception to Capital Recycling Machine
BBU's 2016 founding was designed to democratize access to Brookfield's private equity capabilities, which had compounded value at exceptional rates for over 25 years. This heritage matters because it established a culture of operational excellence before financial engineering—a sequence that proves critical when credit markets tighten and multiple expansion becomes unreliable. The partnership's early investments in Clarios (advanced energy storage), DexKo (engineered components), and Nielsen (audience measurement) were not passive bets on sector tailwinds but active transformations that delivered 40% EBITDA growth at Clarios, $800 million in cost savings at Nielsen, and 200 basis points of margin expansion at DexKo.
Recent history reveals a strategic intensification of capital recycling. The 2024 sale of Westinghouse demonstrated the playbook's maturity: acquire, transform, monetize at premium valuations. This was followed by the July 2024 divestiture of road fuels operations and the January 2025 sale of offshore oil services shuttle tankers. These dispositions generated over $2 billion in proceeds, which management immediately redeployed to repay $1 billion in corporate borrowings, fund $700 million in four new growth acquisitions (Chemelex, Antylia Scientific, First National), and repurchase $235 million of units at approximately $26 per share. This velocity of capital turnover—buying, improving, selling, and reinvesting—creates a compounding flywheel that traditional PE firms cannot match in a public vehicle, as each rotation occurs while maintaining permanent capital.
Technology and Operational Differentiation: AI as Margin Multiplier
BBU's technological edge doesn't reside in a single platform but in its systematic deployment of AI and automation across portfolio companies to drive margin expansion and operational leverage. At Clarios, AI optimizes order intake and executable shipment plans, saving millions in customer service penalties while improving fulfillment quantity by 10% and service performance by 14%. The significance lies in Clarios operating in a cyclical automotive market where volume headwinds would normally compress margins—instead, technology-driven efficiency gains have pushed margins above 20% and supported a 40% increase in underlying EBITDA since acquisition.
The transformation extends beyond manufacturing. At Everise, AI-enabled recruiting reduced training time by 20%, cut hiring costs by 40%, and accelerated hiring speed by 5x across five countries. At CDK, the AVA virtual assistant increased touch points per lead by 4x and sales calls per lead by 47%, directly addressing customer churn risks. Nielsen's AI-driven video segmentation projects $10 million in annual run-rate savings while reducing delivery time from months to days. These aren't pilot projects; they're scaled implementations that demonstrate how operational expertise translates technology into tangible financial results.
Recent U.S. legislation provides a tailwind that competitors without BBU's industrial footprint cannot fully capture. The "Big Beautiful Bill" restores bonus depreciation for industrial businesses like Clarios, DexKo, and Chemelex, enhances R&D deductibility benefiting CDK, and improves interest deductibility. This legislative environment reduces the after-tax cost of the very capital investments BBU uses to drive transformation, effectively subsidizing its competitive moat while peers focused on financial assets see less direct benefit.
Financial Performance: Underlying Strength Beneath Headline Noise
BBU's 2025 full-year adjusted EBITDA of $2.4 billion represents a 6% decline from 2024's $2.6 billion, but this headline figure masks the operational engine's health. Excluding the impact of lower ownership from partial asset sales, tax credits, and acquisitions, same-store adjusted EBITDA grew 10% to $2.1 billion. This divergence is critical: it proves the portfolio's organic earnings power is accelerating despite management actively shrinking its ownership in mature assets. The Industrial segment exemplifies this strength, posting $1.3 billion in EBITDA versus $1.2 billion in 2024, with 10% same-store growth driven by Clarios' favorable product mix and DexKo's margin initiatives.
The Business Services segment generated $823 million in EBITDA, down slightly from $832 million, but same-store growth reached 5%. The residential mortgage insurer Sagen benefited from regulatory changes that increased the insured mortgage cap to $1.5 million and extended amortization to 30 years, driving higher transactional volumes. CDK's performance declined due to technology modernization costs, but management emphasizes these investments are stabilizing churn and extending contract durations beyond three years. This trade-off—near-term margin pressure for long-term customer stickiness—aligns with the operational transformation thesis.
Infrastructure Services saw EBITDA fall to $436 million from $606 million, attributable to the sale of the shuttle tanker operation and partial interest in work access services. The remaining lottery services business at Scientific Games is passing an inflection point, with improved margins and UK market launch success offsetting slower digital lottery legislation. While the segment appears weak on paper, the decline reflects deliberate capital recycling rather than operational deterioration.
Cash generation remains robust. TTM operating cash flow of $3.12 billion and free cash flow of $724 million provide the fuel for capital deployment. The partnership ended 2025 with $2.6 billion in pro forma liquidity, including units received from the secondary sale. Over the past year, BBU completed more than $20 billion in refinancings, extending maturities and reducing borrowing costs by over 50 basis points. Clarios' debt was extended five years to 2032, Modulaire's maturity stretched three years, and Chemelex's spread tightened from SOFR+350 to SOFR+300. These actions lock in low-cost capital for the transformation playbook while peers face refinancing risk in a higher-rate environment.
Outlook and Execution: Catalysts Converging in 2026
Management's guidance for 2026 centers on three catalysts that directly address the valuation discount. First, the corporate reorganization into a single listed corporation is on track to complete over the coming weeks, pending final regulatory approval. This matters because it will improve trading liquidity, double index-driven demand, and simplify the structure for global investors who have avoided the partnership format. The market's positive reaction—consolidated market cap increasing on the announcement—suggests investors recognize the potential for multiple expansion once the discount mechanism is removed.
Second, 2026 is expected to be a very active year for capital deployment. The pipeline includes opportunities in financial infrastructure like Barclays (BCS) Payments, where incumbents struggle to make necessary investments, and industrial consolidation such as the Schoeller Allibert merger that creates a sustainable packaging leader without requiring additional BBU capital. This deployment demonstrates the recycling flywheel is accelerating: proceeds from mature assets are being redeployed into new transformation opportunities at a time when economic uncertainty has created attractive entry valuations.
Third, specific asset monetizations are advancing. Management is evaluating a BRK IPO in Brazil, where the business is delivering double-digit growth and winning new concessions. Latrobe, the pivoted fixed-income asset manager, has re-engaged with potential buyers after resolving regulatory issues and restoring inflows. Clarios is actively considering monetization options including distributions to shareholders. The 45x tax credits —expected to add materially to cash flow—support reinvestment for growth but also enhance exit valuations. These potential realizations would generate fresh capital to recycle into new opportunities or fund additional buybacks.
Execution risks are visible but manageable. CDK's technology modernization costs will continue pressuring margins for 12-18 months, but renewal activity remains strong. Scientific Games' digital lottery pipeline is robust, but earnings recognition lags contract wins by 6-12 months. European cyclical headwinds are impacting DexKo volumes and Modulaire utilization, though both businesses have demonstrated resilience through cost optimization.
Risks and Asymmetries: What Could Break the Thesis
The most material risk is execution failure on the corporate reorganization. While approvals are received and regulatory sign-off is pending, any delay or structural complication would prolong the NAV discount and undermine the investment case. This is a binary outcome: success unlocks institutional capital and index demand, while failure traps BBU in partnership format despite strong underlying performance.
European cyclical exposure represents a fundamental business risk. DexKo's trailer registration volumes remain at multi-year lows, reflecting weak capital investment in construction and manufacturing. Modulaire's utilization is pressured by sluggish European CapEx. While both businesses have proven ability to expand margins through cost actions, a prolonged downturn could limit the pace of recovery. The asymmetry here is that any stabilization in European industrial activity would drive outsized performance given the cost structures have already been rightsized.
Technology modernization at CDK and Scientific Games creates near-term margin risk but long-term competitive necessity. CDK's churn issues stem from legacy product gaps, and the fix requires substantial investment in new technology stacks. Scientific Games' digital transformation demands patience as contracts ramp. If these investments fail to stabilize customers or accelerate growth, the capital allocated would represent value destruction.
Tax credit timing introduces uncertainty. The 45x credits for Clarios are being processed with timing difficult to predict. While management insured a substantial amount and expects IRS payment, the backup insurance claim process could delay cash realization. This matters because the credits represent both a near-term liquidity boost and a validation of the U.S. manufacturing strategy.
Competitive Context: Scale Disadvantage vs. Operational Depth
BBU's competitive positioning reflects a deliberate trade-off. Against Blackstone's $1.3 trillion AUM and Apollo's $938 billion, BBU's effectively $10-15 billion equity portfolio appears diminutive. This scale deficit limits access to mega-deals and contributes to the valuation discount—Blackstone trades at 9.88x book value and 29.23% ROE, while BBU trades at 2.83x book and 2.37% ROE. However, this comparison misses the strategic differentiation. Blackstone's 52.83% operating margin reflects asset management fees, not operational improvement. BBU's 16.66% operating margin and direct control of portfolio companies enable hands-on transformation that a minority-stake model cannot replicate.
KKR's 16% AUM growth and 33.03% operating margin demonstrate superior scale economics, but BBU's same-store EBITDA growth of 10% compares favorably to KKR's more modest organic growth. Apollo's credit-heavy strategy generates stable fees but lacks BBU's industrial upside, while Carlyle's defense-adjacent positioning provides regulatory moats but less exposure to reshoring trends. BBU's niche focus on operational control creates a different return profile: lower fee-related earnings stability but higher potential value creation per dollar invested.
The key competitive advantage is Brookfield's integrated ecosystem. While peers must source deals through competitive auctions, BBU accesses proprietary opportunities within the broader $1 trillion platform. The secondary sale to a Brookfield Evergreen Fund at an 8.6% discount to NAV—immediately accretive given BBU's 50% discount—demonstrates how the ecosystem creates value that standalone competitors cannot replicate. This provides a structural source of deal flow and exit opportunities that reduces risk and enhances returns.
Valuation Context: Pricing the Transformation Gap
At $30.84 per share, BBU trades at an enterprise value of $42.94 billion, representing 5.98x TTM EBITDA and 1.89x free cash flow. These multiples are lower than peers: Blackstone trades at 29.39x free cash flow, KKR at 265.39x, and Apollo at 8.85x. The price-to-operating cash flow ratio of 0.77x suggests the market values BBU's cash generation at a discount to the asset base. This pricing reflects skepticism about the partnership structure and the complexity of valuing a diverse industrial portfolio.
The price-to-book ratio of 2.83x sits at the low end of the peer range (KKR 2.86x, Apollo 2.91x, Carlyle 2.96x), but this comparison is misleading. BBU's book value includes the mark-to-market of industrial assets that are being actively improved, while peers' book values reflect asset management platforms with recurring fee streams. The more relevant metric is the stated discount to intrinsic value. Management's assertion that units trade at a 50% discount to NAV implies a fair value near $60 per share.
The valuation asymmetry is clear: if the reorganization fails and European cyclical pressures mount, the downside is limited by the underlying cash generation ($724M FCF) and liquidity ($2.6B). If the reorganization succeeds and asset monetizations deliver, the upside is substantial as the multiple gap closes. The $250 million buyback program, with $15 million remaining capacity, provides downside protection and per-unit accretion at current prices.
Conclusion: The Convergence of Operation and Structure
Brookfield Business Partners presents a classic value creation story obscured by structural complexity. The operational transformation flywheel—acquiring high-quality businesses, improving performance, and recycling capital—is delivering 10% same-store EBITDA growth and $724 million in free cash flow despite European headwinds and technology investment cycles. This underlying performance validates the 15-20% return target and demonstrates the durability of the strategy across economic cycles.
The investment thesis converges on two variables. First, successful monetization of mature assets like Clarios, BRK, and Latrobe will generate fresh capital to compound the flywheel through new acquisitions or accretive buybacks. Second, the corporate reorganization must unlock institutional demand and narrow the 50% discount to NAV. If both execute, the current $30.84 price offers exposure to a business transforming industrial operations through technology and Brookfield expertise, priced as if those transformations will fail.
The asymmetry favors long-term investors. Downside is cushioned by strong cash generation, no near-term debt maturities, and a proven ability to navigate cyclical pressures. Upside is driven by multiple expansion as the market recognizes the quality of the underlying portfolio and the efficacy of the operational model. In an environment where deglobalization and AI implementation require experienced operators, BBU's integrated model becomes more valuable, making the structural discount an opportunity rather than a permanent handicap.
